<DOC>
	<DOC>NCT02804932</DOC>
	<brief_summary>The purpose of this study is to use a randomized, double-blind, placebo controlled study design to comprehensively investigate the impact of 8-weeks of dietary nitrate supplementation on skeletal muscle blood flow, mitochondrial function, and exercise capacity in patients with type 2 diabetes (T2D).</brief_summary>
	<brief_title>Nitrate Supplementation and Exercise Tolerance in Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>For 50 patients with documented Type 2 diabetes Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any researchrelated procedures. Age is &gt; or = 40 and &lt; or = 70 years of age Documented Type 2 diabetes diagnosis of type 2 diabetes &lt; 3 years prior to enrollment HbA1c &lt;6.0% or &gt;10.0% body mass index &gt; 40 kg/m2 incident cardiovascular events in the last year (heart attack, stroke) symptomatic coronary artery disease and/or heart failure uncontrolled hypertension hypotension (resting systolic BP &lt; 90 mmHg) renal impairment with creatinine clearance (eGFR) of &lt;50 ml/min insulin use smoking or history of smoking within past one year use of medication which contain nitrates use of anticoagulant drugs use of antiplatelet drugs participation in research studies in which medications or interventions are given which would potentially alter subject responses in the current study For 15 age and weightmatched nondiabetic control subjects Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any researchrelated procedures. Age is &gt; or = 40 and &lt; or = 70 years of age Diagnosis of diabetes (Type 1 or Type 2) body mass index &gt; 40 kg/m2 incident cardiovascular events in the last year (heart attack, stroke) symptomatic coronary artery disease and/or heart failure uncontrolled hypertension hypotension (resting systolic BP &lt; 90 mmHg) renal impairment with creatinine clearance (eGFR) of &lt;50 ml/min insulin use smoking or history of smoking within past one year use of medication which contain nitrates use of anticoagulant drugs use of antiplatelet drugs participation in research studies in which medications or interventions are given which would potentially alter subject responses in the current study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>